UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026550
Receipt number R000030487
Scientific Title A study on clinical outcomes of endoscopic submucosal dissection for superficial neoplasms in the cervical esophagus
Date of disclosure of the study information 2017/03/15
Last modified on 2019/03/19 17:32:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on clinical outcomes of endoscopic submucosal dissection for superficial neoplasms in the cervical esophagus

Acronym

Clinical outcomes of endoscopic submucosal dissection in the cervical esophagus

Scientific Title

A study on clinical outcomes of endoscopic submucosal dissection for superficial neoplasms in the cervical esophagus

Scientific Title:Acronym

Clinical outcomes of endoscopic submucosal dissection in the cervical esophagus

Region

Japan


Condition

Condition

esophageal neoplasms

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the clinical outcomes of endoscopic submucosal dissection including the cervical esophagus

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

en bloc resection of tumor

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who diagnosed with esophageal superficial neoplasms.
Patients with neoplasms extending to the cervical esophagus.
Patients who underwent endoscopic submucosal dissection in Kobe university hospital between July 1,2003 and November 31,2015.

Key exclusion criteria

Patients who had previously undergone surgery on the pharyngolarynx or esophagus.

Target sample size

26


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Toyonaga

Organization

Kobe University Hospital

Division name

Department of Endoscopy

Zip code

650-0052

Address

7-5-2,Kusunoki-Cho, Chuo-Ku,Kobe-City,Hyogo

TEL

078-382-6305

Email

toyonaga@bf7.so-net.ne.jp


Public contact

Name of contact person

1st name Ryusuke
Middle name
Last name Ariyoshi

Organization

Kobe University Hospital

Division name

Department of Endoscopy

Zip code

650-0052

Address

7-5-2,Kusunoki-Cho, Chuo-Ku,Kobe-City,Hyogo

TEL

078-382-6305

Homepage URL


Email

arysrsk@gmail.com


Sponsor or person

Institute

Kobe University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital Clinical & Translational Reseach Center

Address

7-5-2,Kusunoki-Cho, Chuo-Ku,Kobe-City,Hyogo

Tel

078-382-6669

Email

kansatsu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

26

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 08 Month 17 Day

Date of IRB

2016 Year 08 Month 17 Day

Anticipated trial start date

2016 Year 08 Month 17 Day

Last follow-up date

2017 Year 03 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is an observational study. The clinical data of patients were obtained from the medical records of our institution.


Management information

Registered date

2017 Year 03 Month 14 Day

Last modified on

2019 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030487